dapansutrile capsules

DRUG2 trials

Sponsors

Olatec Therapeutics LLC

Conditions

Covid19Cytokine Release SyndromeSystolic Heart Failure

Phase 1

Study of Dapansutrile Capsules in Heart Failure

CompletedNCT03534297

Olatec Therapeutics LLCSystolic Heart Failure

Start: 2018-05-16End: 2019-11-21Updated: 2020-01-09

Phase 2

Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome

TerminatedNCT04540120

Olatec Therapeutics LLCCovid19, Cytokine Release Syndrome

Start: 2020-09-24End: 2022-07-28Updated: 2023-04-13